Use of the BIOGROUP <sup>®</sup> French laboratories database to conduct CKD observational studies: a pilot EPI-CKD1 study
The EPI-CKD1 study demonstrates the utility of Biogroup<sup>®</sup> data for large-scale observational studies, offering precise, medically relevant insights on patients at cardio-renal risk. Future studies should focus on data enrichment and long-term follow-up to deepen understanding.
Authors
- F. Raguideau (ORCID: https://orcid.org/0000-0002-7611-371X)
- Cécile Conte (ORCID: https://orcid.org/0000-0002-7787-5740)
- Guillaume Pénaranda (ORCID: https://orcid.org/0000-0002-7461-4254)
- Philippe Zaoui
- Claire Visseaux
- Julien L’hirondel
- Claire Vignault
- Isabelle Sebaoun-Rivière
Institutions
- Alliance Université-Entreprise de Grenoble (FR)
- Alphabio (FR)
- Université Grenoble Alpes (FR)
Publication Details
- Journal
- Clinical Chemistry and Laboratory Medicine (CCLM)
- Published
- 2025-03-18
- DOI
- https://doi.org/10.1515/cclm-2024-1399
- Primary Topic
- Chronic Kidney Disease and Diabetes
- Type
- article
- Field-Weighted Citation Impact
- 0.00